Protalex, Inc.   Report issue

For profit Phase 2
Founded: Florham Park NJ United States (1999)
Status: Defunct (2020)

Organization Overview

First Clinical Trial
2007
NCT00517855
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

prtx-100 (6 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 2)

Arthritis, Rheumatoid (Phase 2)

Purpura (Phase 1)

Purpura, Thrombocytopenic (Phase 1)

Purpura, Thrombocytopenic, Idiopathic (Phase 2)

Thrombocytopenia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 1